Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Huemer

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Oncotarget|April 18, 2018
Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancerFlorian Huemer, Gabriel Rinnerthaler, Theresa Westphal, et al.
Wiener Klinische Wochenschrift|November 24, 2016
Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case reportFlorian Huemer, Martin Dejaco, Christoph Grabmer, et al.
Journal of Clinical Medicine|November 14, 2019
C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling overall survival Prediction in Pancreatic Cancer PatientsKonstantin Schlick, Teresa Magnes, Florian Huemer, et al.
Cancers|January 11, 2022
Sex-Based Clinical Outcome in Advanced NSCLC Patients Undergoing PD-1/PD-L1 Inhibitor Therapy-A Retrospective Bi-Centric Cohort StudyDavid Lang, Anna Brauner, Florian Huemer, et al.
World Neurosurgery|September 27, 2018
Extensive Leptomeningeal Intracranial and Spinal Metastases in a Patient with a Supratentorial Glioblastoma Multiforme, IDH-WildtypeChristoph Schwartz, Alexander Romagna, Lukas Machegger, et al.
Journal of Clinical Medicine|July 13, 2019
Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 BlockadeFlorian Huemer, David Lang, Theresa Westphal, et al.
Geroscience|April 10, 2021
Results of a hospitalization policy of asymptomatic and pre-symptomatic COVID-19-positive long-term care facility residents in the province of Salzburg-a report from the AGMT COVID-19 RegistryFlorian Huemer, Gabriel Rinnerthaler, Benedikt Jörg, et al.
Targeted Oncology|October 27, 2019
Therapy Line and Associated Predictors of Response to PD-1/PD-L1-Inhibitor Monotherapy in Advanced Non-small-Cell Lung Cancer: A Retrospective Bi-centric Cohort StudyDavid Lang, Florian Huemer, Gabriel Rinnerthaler, et al.
Frontiers in Oncology|August 10, 2023
Management of metastatic colorectal cancer in patients ≥70 years - a single center experienceFlorian Huemer, Celine Dunkl, Gabriel Rinnerthaler, et al.
Anticancer Research|October 7, 2017
Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3Ewald Wöll, Josef Thaler, Felix Keil, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Oncotarget|April 18, 2018
Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancerFlorian Huemer, Gabriel Rinnerthaler, Theresa Westphal, et al.
Wiener Klinische Wochenschrift|November 24, 2016
Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case reportFlorian Huemer, Martin Dejaco, Christoph Grabmer, et al.
Journal of Clinical Medicine|November 14, 2019
C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling overall survival Prediction in Pancreatic Cancer PatientsKonstantin Schlick, Teresa Magnes, Florian Huemer, et al.
Cancers|January 11, 2022
Sex-Based Clinical Outcome in Advanced NSCLC Patients Undergoing PD-1/PD-L1 Inhibitor Therapy-A Retrospective Bi-Centric Cohort StudyDavid Lang, Anna Brauner, Florian Huemer, et al.
World Neurosurgery|September 27, 2018
Extensive Leptomeningeal Intracranial and Spinal Metastases in a Patient with a Supratentorial Glioblastoma Multiforme, IDH-WildtypeChristoph Schwartz, Alexander Romagna, Lukas Machegger, et al.
Journal of Clinical Medicine|July 13, 2019
Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 BlockadeFlorian Huemer, David Lang, Theresa Westphal, et al.
Geroscience|April 10, 2021
Results of a hospitalization policy of asymptomatic and pre-symptomatic COVID-19-positive long-term care facility residents in the province of Salzburg-a report from the AGMT COVID-19 RegistryFlorian Huemer, Gabriel Rinnerthaler, Benedikt Jörg, et al.
Targeted Oncology|October 27, 2019
Therapy Line and Associated Predictors of Response to PD-1/PD-L1-Inhibitor Monotherapy in Advanced Non-small-Cell Lung Cancer: A Retrospective Bi-centric Cohort StudyDavid Lang, Florian Huemer, Gabriel Rinnerthaler, et al.
Frontiers in Oncology|August 10, 2023
Management of metastatic colorectal cancer in patients ≥70 years - a single center experienceFlorian Huemer, Celine Dunkl, Gabriel Rinnerthaler, et al.
Anticancer Research|October 7, 2017
Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3Ewald Wöll, Josef Thaler, Felix Keil, et al.
Pageof 5